Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04009447 · ClinicalTrials.gov registry record · NA

Sleep Quality and Mechanisms of Cardiovascular Risks in Adults With Hypertension

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
149
Enrollment target

NCT04009447: Completed NA study, sponsored by Duke University.

NCT04009447 is a NA study that has completed, run by Duke University. The registered enrollment target is 149 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04009447, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target

Study Summary

The objective of this study is to elucidate the potential mechanisms responsible for the increased risk of cardiovascular disease among patients with hypertension and comorbid insomnia.

Primary Outcome

Average nighttime blood pressure measured before CBT-I (Cognitive Behavioral Therapy for Insomnia) (baseline) and after CBT-I (6 months post-intervention).

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBT-I)

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2020-02-14
Est. Completion 2025-01-02
Phase NA
Duke University

1,725 total trials

What the finished NCT04009447 record still lists

NCT04009447 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first listed.

NCT04009447 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04009447 about?

NCT04009447 is a clinical study titled "Sleep Quality and Mechanisms of Cardiovascular Risks in Adults With Hypertension". The objective of this study is to elucidate the potential mechanisms responsible for the increased risk of cardiovascular disease among patients with hypertension and comorbid insomnia.

What is the current status of trial NCT04009447?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2020-02-14. Estimated completion is 2025-01-02.

What interventions are being tested in trial NCT04009447?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04009447?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04009447's enrollment target sits among peer trials

149 702nd of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04009447, the US trial registry maintained by the National Library of Medicine. NCT04009447 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.